Stockholders’ Equity - Narrative (Details) $ / shares in Units, $ in Millions	Apr. 06, 2022 USD ($) $ / shares	Mar. 31, 2025 USD ($) $ / shares shares	Dec. 31, 2024 $ / shares shares	Nov. 13, 2024 USD ($)	Jan. 02, 2024 USD ($) $ / shares shares
Class of Stock [Line Items]
Preferred shares, shares authorized (in shares) | shares		2,000,000	2,000,000
Preferred shares, par value (in dollars per share) | $ / shares		$ 0.0001	$ 0.0001
Preferred shares, shares issued (in shares) | shares		15,000	15,000
Preferred shares, shares outstanding (in shares) | shares		15,000	15,000
Loan and Security Agreement, Term loan | Term loan
Class of Stock [Line Items]
Common stock issuable upon exercise of pre-funded warrants (in shares) | shares					191,096
Exercise price of warrant (in dollars per share) | $ / shares					$ 1.83
Fair value of warrant					$ 0.2
Series X Convertible Preferred Stock
Class of Stock [Line Items]
Interest rate percentage	1.00%
Common stock trading price (in dollars per share) | $ / shares	$ 22.00
Common stock trading period	30 days
Accreted amount		$ 0.3
Conversion price (in dollars per share) | $ / shares	$ 11.00
Convertible preferred stock (in shares)	91
Outstanding common stock, percentage	9.90%
Outstanding common stock, not to exceed, percentage	19.90%
Percentage of investment owned	50.00%
Maximum working capital line	$ 5.0
Consideration received	15.0
Stock issuance costs	0.1
Proceeds from sale of equity, net	14.9
Da Vita Healthcare Partners Inc | Series X Convertible Preferred Stock | Private Placement
Class of Stock [Line Items]
Sale of stock, aggregate consideration authorized	$ 15.0
Common stock trading price (in dollars per share) | $ / shares	$ 1,000
Cantor Fitzgerald & Co | At-the-Market Offering
Class of Stock [Line Items]
Sale of stock, aggregate consideration authorized				$ 25.0
Remaining consideration on ATM facility		$ 21.1